Intrathecal administration of an NMDA or a non-NMDA receptor antagonist reduces mechanical but not thermal allodynia in a rodent model of chronic central pain after spinal cord injury

Spinal cord injuries (SCI) result in a devastating loss of function and chronic central pain syndromes frequently develop in the majority of these patients. The present study uses a rodent spinal hemisection model of SCI in which mechanical and thermal allodynia develops by 24 days after injury. Pos...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Brain research 2000-03, Vol.859 (1), p.72-82
Hauptverfasser: Bennett, Adrianne D., Everhart, Alex W., Hulsebosch, Claire E.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 82
container_issue 1
container_start_page 72
container_title Brain research
container_volume 859
creator Bennett, Adrianne D.
Everhart, Alex W.
Hulsebosch, Claire E.
description Spinal cord injuries (SCI) result in a devastating loss of function and chronic central pain syndromes frequently develop in the majority of these patients. The present study uses a rodent spinal hemisection model of SCI in which mechanical and thermal allodynia develops by 24 days after injury. Post-operative paw withdrawal responses to low threshold and high threshold mechanical stimuli compared to pre-operative responses (4.78, 9.96, and 49.9 mN) were increased and were statistically significant ( p
doi_str_mv 10.1016/S0006-8993(99)02483-X
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70985915</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S000689939902483X</els_id><sourcerecordid>17492259</sourcerecordid><originalsourceid>FETCH-LOGICAL-c421t-60bcd04a2f2f78c88e51ef4d1d0d0942609856291d0b4abfbb78b8ace718ab513</originalsourceid><addsrcrecordid>eNqFkcFu1DAQhiMEotvCI4B8QAgOAdtxEvuEqlKgUoEDIPVmOfaEdZXYqe0g7ZPxeti7K-DW02hG3__PaP6qekbwG4JJ9_YbxriruRDNKyFeY8p4U988qDaE97TuKMMPq81f5KQ6jfE2t00j8OPqhOCe4o50m-r3lUtBpS1oNSFlZutsLAPrHfIjUg59-fz-HPmAFHLe1fsugIYllZlL6qcvkjwzq4aIZtBb5WyxG9aUNQll9zAX-2nyZuesQtZlu-ANuITmXKayS29DttJIQzlpQosq2JggoLhYlyfaB5O1t2vYPakejWqK8PRYz6ofHy6_X3yqr79-vLo4v641oyTVHR60wUzRkY4915xDS2BkhhhssGC0w4K3HRW5H5gaxmHo-cCVhp5wNbSkOateHnyX4O9WiEnONmqYJuXAr1H2xUCQ9l6Q9ExQ2ooMtgdQBx9jgFEuwc4q7CTBskQr99HKkpsUQu6jlTdZ9_y4YB1mMP-pDllm4MURUDG_fwzKaRv_cVQw1uCMvTtgkN_2y0KQUVtwGozNuSZpvL3nkj-PaMOo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17492259</pqid></control><display><type>article</type><title>Intrathecal administration of an NMDA or a non-NMDA receptor antagonist reduces mechanical but not thermal allodynia in a rodent model of chronic central pain after spinal cord injury</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Bennett, Adrianne D. ; Everhart, Alex W. ; Hulsebosch, Claire E.</creator><creatorcontrib>Bennett, Adrianne D. ; Everhart, Alex W. ; Hulsebosch, Claire E.</creatorcontrib><description>Spinal cord injuries (SCI) result in a devastating loss of function and chronic central pain syndromes frequently develop in the majority of these patients. The present study uses a rodent spinal hemisection model of SCI in which mechanical and thermal allodynia develops by 24 days after injury. Post-operative paw withdrawal responses to low threshold and high threshold mechanical stimuli compared to pre-operative responses (4.78, 9.96, and 49.9 mN) were increased and were statistically significant ( p&lt;0.05) for both forelimbs and hindlimbs indicating the development of mechanical allodynia. By contrast, post-operatively, the temperature at which paw withdrawal accompanied by paw lick occurred was significantly decreased ( p&lt;0.05), indicating the development of thermal allodynia. The intrathecal application of either D-AP5, a competitive NMDA receptor antagonist, or NBQX-disodium salt, a competitive non-NMDA AMPA/kainate receptor antagonist, alleviated the mechanical allodynia and lowered the threshold of response for the high threshold mechanical stimuli in a dose-dependent manner, and these decreases were statistically significant ( p&lt;0.05). By contrast, neither the D-AP5 nor the NBQX produced a statistically significant change in the thermal allodynia behavior in either forelimbs or hindlimbs in the hemisected group. No significant changes in locomotion scores, and thus no sedation, were demonstrated by the hemisected group for the doses tested. These data support the potential efficacy of competitive excitatory amino acid receptor antagonists in the treatment of chronic central pain, particularly where input from low threshold mechanical afferents trigger the onset of the painful sensation. Furthermore, these data suggest a role for both NMDA and non-NMDA receptors in the development of plastic changes in the spinal cord that provide the underlying mechanisms for central neuropathic pain.</description><identifier>ISSN: 0006-8993</identifier><identifier>EISSN: 1872-6240</identifier><identifier>DOI: 10.1016/S0006-8993(99)02483-X</identifier><identifier>PMID: 10720616</identifier><identifier>CODEN: BRREAP</identifier><language>eng</language><publisher>London: Elsevier B.V</publisher><subject>Allodynia ; AMPA ; Animals ; Biological and medical sciences ; Cerebrospinal fluid. Meninges. Spinal cord ; Chronic Disease ; Disease Models, Animal ; Dose-Response Relationship, Drug ; EAA ; Excitatory Amino Acid Antagonists - pharmacology ; Hyperalgesia - drug therapy ; Hyperalgesia - physiopathology ; Injections, Spinal ; Male ; Medical sciences ; Motor Activity - physiology ; Nervous system (semeiology, syndromes) ; Neurology ; NMDA ; Pain ; Pain - drug therapy ; Pain - physiopathology ; Physical Stimulation ; Quinoxalines - pharmacology ; Rats ; Rats, Sprague-Dawley ; Reaction Time - drug effects ; Reaction Time - physiology ; Receptors, N-Methyl-D-Aspartate - antagonists &amp; inhibitors ; Rodentia ; Spinal Cord - drug effects ; Spinal Cord - physiopathology ; Spinal Cord - surgery ; Spinal Cord Injuries - drug therapy ; Spinal Cord Injuries - physiopathology ; Spinal cord injury ; Spinal hemisection ; Valine - analogs &amp; derivatives ; Valine - pharmacology</subject><ispartof>Brain research, 2000-03, Vol.859 (1), p.72-82</ispartof><rights>2000 Elsevier Science B.V.</rights><rights>2000 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c421t-60bcd04a2f2f78c88e51ef4d1d0d0942609856291d0b4abfbb78b8ace718ab513</citedby><cites>FETCH-LOGICAL-c421t-60bcd04a2f2f78c88e51ef4d1d0d0942609856291d0b4abfbb78b8ace718ab513</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S000689939902483X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1294430$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10720616$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bennett, Adrianne D.</creatorcontrib><creatorcontrib>Everhart, Alex W.</creatorcontrib><creatorcontrib>Hulsebosch, Claire E.</creatorcontrib><title>Intrathecal administration of an NMDA or a non-NMDA receptor antagonist reduces mechanical but not thermal allodynia in a rodent model of chronic central pain after spinal cord injury</title><title>Brain research</title><addtitle>Brain Res</addtitle><description>Spinal cord injuries (SCI) result in a devastating loss of function and chronic central pain syndromes frequently develop in the majority of these patients. The present study uses a rodent spinal hemisection model of SCI in which mechanical and thermal allodynia develops by 24 days after injury. Post-operative paw withdrawal responses to low threshold and high threshold mechanical stimuli compared to pre-operative responses (4.78, 9.96, and 49.9 mN) were increased and were statistically significant ( p&lt;0.05) for both forelimbs and hindlimbs indicating the development of mechanical allodynia. By contrast, post-operatively, the temperature at which paw withdrawal accompanied by paw lick occurred was significantly decreased ( p&lt;0.05), indicating the development of thermal allodynia. The intrathecal application of either D-AP5, a competitive NMDA receptor antagonist, or NBQX-disodium salt, a competitive non-NMDA AMPA/kainate receptor antagonist, alleviated the mechanical allodynia and lowered the threshold of response for the high threshold mechanical stimuli in a dose-dependent manner, and these decreases were statistically significant ( p&lt;0.05). By contrast, neither the D-AP5 nor the NBQX produced a statistically significant change in the thermal allodynia behavior in either forelimbs or hindlimbs in the hemisected group. No significant changes in locomotion scores, and thus no sedation, were demonstrated by the hemisected group for the doses tested. These data support the potential efficacy of competitive excitatory amino acid receptor antagonists in the treatment of chronic central pain, particularly where input from low threshold mechanical afferents trigger the onset of the painful sensation. Furthermore, these data suggest a role for both NMDA and non-NMDA receptors in the development of plastic changes in the spinal cord that provide the underlying mechanisms for central neuropathic pain.</description><subject>Allodynia</subject><subject>AMPA</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Cerebrospinal fluid. Meninges. Spinal cord</subject><subject>Chronic Disease</subject><subject>Disease Models, Animal</subject><subject>Dose-Response Relationship, Drug</subject><subject>EAA</subject><subject>Excitatory Amino Acid Antagonists - pharmacology</subject><subject>Hyperalgesia - drug therapy</subject><subject>Hyperalgesia - physiopathology</subject><subject>Injections, Spinal</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Motor Activity - physiology</subject><subject>Nervous system (semeiology, syndromes)</subject><subject>Neurology</subject><subject>NMDA</subject><subject>Pain</subject><subject>Pain - drug therapy</subject><subject>Pain - physiopathology</subject><subject>Physical Stimulation</subject><subject>Quinoxalines - pharmacology</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Reaction Time - drug effects</subject><subject>Reaction Time - physiology</subject><subject>Receptors, N-Methyl-D-Aspartate - antagonists &amp; inhibitors</subject><subject>Rodentia</subject><subject>Spinal Cord - drug effects</subject><subject>Spinal Cord - physiopathology</subject><subject>Spinal Cord - surgery</subject><subject>Spinal Cord Injuries - drug therapy</subject><subject>Spinal Cord Injuries - physiopathology</subject><subject>Spinal cord injury</subject><subject>Spinal hemisection</subject><subject>Valine - analogs &amp; derivatives</subject><subject>Valine - pharmacology</subject><issn>0006-8993</issn><issn>1872-6240</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkcFu1DAQhiMEotvCI4B8QAgOAdtxEvuEqlKgUoEDIPVmOfaEdZXYqe0g7ZPxeti7K-DW02hG3__PaP6qekbwG4JJ9_YbxriruRDNKyFeY8p4U988qDaE97TuKMMPq81f5KQ6jfE2t00j8OPqhOCe4o50m-r3lUtBpS1oNSFlZutsLAPrHfIjUg59-fz-HPmAFHLe1fsugIYllZlL6qcvkjwzq4aIZtBb5WyxG9aUNQll9zAX-2nyZuesQtZlu-ANuITmXKayS29DttJIQzlpQosq2JggoLhYlyfaB5O1t2vYPakejWqK8PRYz6ofHy6_X3yqr79-vLo4v641oyTVHR60wUzRkY4915xDS2BkhhhssGC0w4K3HRW5H5gaxmHo-cCVhp5wNbSkOateHnyX4O9WiEnONmqYJuXAr1H2xUCQ9l6Q9ExQ2ooMtgdQBx9jgFEuwc4q7CTBskQr99HKkpsUQu6jlTdZ9_y4YB1mMP-pDllm4MURUDG_fwzKaRv_cVQw1uCMvTtgkN_2y0KQUVtwGozNuSZpvL3nkj-PaMOo</recordid><startdate>20000317</startdate><enddate>20000317</enddate><creator>Bennett, Adrianne D.</creator><creator>Everhart, Alex W.</creator><creator>Hulsebosch, Claire E.</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>20000317</creationdate><title>Intrathecal administration of an NMDA or a non-NMDA receptor antagonist reduces mechanical but not thermal allodynia in a rodent model of chronic central pain after spinal cord injury</title><author>Bennett, Adrianne D. ; Everhart, Alex W. ; Hulsebosch, Claire E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c421t-60bcd04a2f2f78c88e51ef4d1d0d0942609856291d0b4abfbb78b8ace718ab513</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Allodynia</topic><topic>AMPA</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Cerebrospinal fluid. Meninges. Spinal cord</topic><topic>Chronic Disease</topic><topic>Disease Models, Animal</topic><topic>Dose-Response Relationship, Drug</topic><topic>EAA</topic><topic>Excitatory Amino Acid Antagonists - pharmacology</topic><topic>Hyperalgesia - drug therapy</topic><topic>Hyperalgesia - physiopathology</topic><topic>Injections, Spinal</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Motor Activity - physiology</topic><topic>Nervous system (semeiology, syndromes)</topic><topic>Neurology</topic><topic>NMDA</topic><topic>Pain</topic><topic>Pain - drug therapy</topic><topic>Pain - physiopathology</topic><topic>Physical Stimulation</topic><topic>Quinoxalines - pharmacology</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Reaction Time - drug effects</topic><topic>Reaction Time - physiology</topic><topic>Receptors, N-Methyl-D-Aspartate - antagonists &amp; inhibitors</topic><topic>Rodentia</topic><topic>Spinal Cord - drug effects</topic><topic>Spinal Cord - physiopathology</topic><topic>Spinal Cord - surgery</topic><topic>Spinal Cord Injuries - drug therapy</topic><topic>Spinal Cord Injuries - physiopathology</topic><topic>Spinal cord injury</topic><topic>Spinal hemisection</topic><topic>Valine - analogs &amp; derivatives</topic><topic>Valine - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bennett, Adrianne D.</creatorcontrib><creatorcontrib>Everhart, Alex W.</creatorcontrib><creatorcontrib>Hulsebosch, Claire E.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Brain research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bennett, Adrianne D.</au><au>Everhart, Alex W.</au><au>Hulsebosch, Claire E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Intrathecal administration of an NMDA or a non-NMDA receptor antagonist reduces mechanical but not thermal allodynia in a rodent model of chronic central pain after spinal cord injury</atitle><jtitle>Brain research</jtitle><addtitle>Brain Res</addtitle><date>2000-03-17</date><risdate>2000</risdate><volume>859</volume><issue>1</issue><spage>72</spage><epage>82</epage><pages>72-82</pages><issn>0006-8993</issn><eissn>1872-6240</eissn><coden>BRREAP</coden><abstract>Spinal cord injuries (SCI) result in a devastating loss of function and chronic central pain syndromes frequently develop in the majority of these patients. The present study uses a rodent spinal hemisection model of SCI in which mechanical and thermal allodynia develops by 24 days after injury. Post-operative paw withdrawal responses to low threshold and high threshold mechanical stimuli compared to pre-operative responses (4.78, 9.96, and 49.9 mN) were increased and were statistically significant ( p&lt;0.05) for both forelimbs and hindlimbs indicating the development of mechanical allodynia. By contrast, post-operatively, the temperature at which paw withdrawal accompanied by paw lick occurred was significantly decreased ( p&lt;0.05), indicating the development of thermal allodynia. The intrathecal application of either D-AP5, a competitive NMDA receptor antagonist, or NBQX-disodium salt, a competitive non-NMDA AMPA/kainate receptor antagonist, alleviated the mechanical allodynia and lowered the threshold of response for the high threshold mechanical stimuli in a dose-dependent manner, and these decreases were statistically significant ( p&lt;0.05). By contrast, neither the D-AP5 nor the NBQX produced a statistically significant change in the thermal allodynia behavior in either forelimbs or hindlimbs in the hemisected group. No significant changes in locomotion scores, and thus no sedation, were demonstrated by the hemisected group for the doses tested. These data support the potential efficacy of competitive excitatory amino acid receptor antagonists in the treatment of chronic central pain, particularly where input from low threshold mechanical afferents trigger the onset of the painful sensation. Furthermore, these data suggest a role for both NMDA and non-NMDA receptors in the development of plastic changes in the spinal cord that provide the underlying mechanisms for central neuropathic pain.</abstract><cop>London</cop><cop>Amsterdam</cop><cop>New York, NY</cop><pub>Elsevier B.V</pub><pmid>10720616</pmid><doi>10.1016/S0006-8993(99)02483-X</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0006-8993
ispartof Brain research, 2000-03, Vol.859 (1), p.72-82
issn 0006-8993
1872-6240
language eng
recordid cdi_proquest_miscellaneous_70985915
source MEDLINE; Elsevier ScienceDirect Journals
subjects Allodynia
AMPA
Animals
Biological and medical sciences
Cerebrospinal fluid. Meninges. Spinal cord
Chronic Disease
Disease Models, Animal
Dose-Response Relationship, Drug
EAA
Excitatory Amino Acid Antagonists - pharmacology
Hyperalgesia - drug therapy
Hyperalgesia - physiopathology
Injections, Spinal
Male
Medical sciences
Motor Activity - physiology
Nervous system (semeiology, syndromes)
Neurology
NMDA
Pain
Pain - drug therapy
Pain - physiopathology
Physical Stimulation
Quinoxalines - pharmacology
Rats
Rats, Sprague-Dawley
Reaction Time - drug effects
Reaction Time - physiology
Receptors, N-Methyl-D-Aspartate - antagonists & inhibitors
Rodentia
Spinal Cord - drug effects
Spinal Cord - physiopathology
Spinal Cord - surgery
Spinal Cord Injuries - drug therapy
Spinal Cord Injuries - physiopathology
Spinal cord injury
Spinal hemisection
Valine - analogs & derivatives
Valine - pharmacology
title Intrathecal administration of an NMDA or a non-NMDA receptor antagonist reduces mechanical but not thermal allodynia in a rodent model of chronic central pain after spinal cord injury
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T19%3A48%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Intrathecal%20administration%20of%20an%20NMDA%20or%20a%20non-NMDA%20receptor%20antagonist%20reduces%20mechanical%20but%20not%20thermal%20allodynia%20in%20a%20rodent%20model%20of%20chronic%20central%20pain%20after%20spinal%20cord%20injury&rft.jtitle=Brain%20research&rft.au=Bennett,%20Adrianne%20D.&rft.date=2000-03-17&rft.volume=859&rft.issue=1&rft.spage=72&rft.epage=82&rft.pages=72-82&rft.issn=0006-8993&rft.eissn=1872-6240&rft.coden=BRREAP&rft_id=info:doi/10.1016/S0006-8993(99)02483-X&rft_dat=%3Cproquest_cross%3E17492259%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17492259&rft_id=info:pmid/10720616&rft_els_id=S000689939902483X&rfr_iscdi=true